Mojca Kerec Kos

445 total citations
25 papers, 328 citations indexed

About

Mojca Kerec Kos is a scholar working on Urology, Epidemiology and Pharmacology. According to data from OpenAlex, Mojca Kerec Kos has authored 25 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Urology, 6 papers in Epidemiology and 5 papers in Pharmacology. Recurrent topics in Mojca Kerec Kos's work include Urinary Bladder and Prostate Research (6 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Pharmaceutical Practices and Patient Outcomes (4 papers). Mojca Kerec Kos is often cited by papers focused on Urinary Bladder and Prostate Research (6 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Pharmaceutical Practices and Patient Outcomes (4 papers). Mojca Kerec Kos collaborates with scholars based in Slovenia, Germany and United Kingdom. Mojca Kerec Kos's co-authors include Mitja Lainščak, Jochen Springer, Aleš Mrhar, Peter Veranič, Stefan D. Anker, Marija Bogataj, Stephan von Haehling, Andreja Erman, Jurij Trontelj and Iztok Grabnar and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and The Journal of Infectious Diseases.

In The Last Decade

Mojca Kerec Kos

25 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mojca Kerec Kos Slovenia 10 56 52 48 47 45 25 328
Shih‐Yu Chen Taiwan 14 56 1.0× 44 0.8× 41 0.9× 43 0.9× 50 1.1× 33 462
Molouk Hadjibabaie Iran 11 34 0.6× 38 0.7× 61 1.3× 44 0.9× 27 0.6× 32 414
Hong Lu United States 11 59 1.1× 35 0.7× 77 1.6× 70 1.5× 32 0.7× 23 345
Sadık Görür Türkiye 12 94 1.7× 26 0.5× 26 0.5× 45 1.0× 21 0.5× 30 367
Afshin Safaei Asl Iran 11 64 1.1× 57 1.1× 23 0.5× 14 0.3× 26 0.6× 33 322
Anders Rosén Sweden 9 64 1.1× 20 0.4× 25 0.5× 27 0.6× 21 0.5× 24 350
Dennis H. Giesing United States 11 74 1.3× 28 0.5× 110 2.3× 52 1.1× 30 0.7× 18 479
Vural Kesik Türkiye 12 93 1.7× 33 0.6× 71 1.5× 48 1.0× 66 1.5× 43 487
Kousalya Prabahar Saudi Arabia 11 44 0.8× 20 0.4× 47 1.0× 13 0.3× 33 0.7× 99 503
Vincent P. Gotz United States 13 91 1.6× 38 0.7× 76 1.6× 43 0.9× 52 1.2× 50 557

Countries citing papers authored by Mojca Kerec Kos

Since Specialization
Citations

This map shows the geographic impact of Mojca Kerec Kos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mojca Kerec Kos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mojca Kerec Kos more than expected).

Fields of papers citing papers by Mojca Kerec Kos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mojca Kerec Kos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mojca Kerec Kos. The network helps show where Mojca Kerec Kos may publish in the future.

Co-authorship network of co-authors of Mojca Kerec Kos

This figure shows the co-authorship network connecting the top 25 collaborators of Mojca Kerec Kos. A scholar is included among the top collaborators of Mojca Kerec Kos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mojca Kerec Kos. Mojca Kerec Kos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kos, Mitja, et al.. (2024). Pharmacist-led hospital intervention reduces unintentional patient-generated medication discrepancies after hospital discharge. Frontiers in Pharmacology. 15. 1483932–1483932. 1 indexed citations
2.
3.
4.
Kos, Mojca Kerec, et al.. (2023). Sex-Dependent Differences in Blood–Urine Barrier Are Subtle but Significant in Healthy and Chronically Inflamed Mouse Bladders. International Journal of Molecular Sciences. 24(22). 16296–16296. 1 indexed citations
5.
Grabnar, Iztok, et al.. (2023). External validation of population pharmacokinetic models of gentamicin in paediatric population from preterm newborns to adolescents. Acta Pharmaceutica. 73(2). 175–194. 1 indexed citations
6.
Kos, Mojca Kerec, et al.. (2021). Incidence and control of steroid-induced hyperglycaemia in hospitalised patients at a tertiary care centre for lung diseases. Pharmacological Reports. 73(3). 796–805. 7 indexed citations
7.
Mrhar, Aleš, et al.. (2021). Adverse drug events during transitions of care. Wiener klinische Wochenschrift. 134(3-4). 130–138. 6 indexed citations
8.
Kos, Mojca Kerec, et al.. (2020). Sensitivity of Different In Vitro Performance Tests and Their In Vivo Relevance for Calcipotriol/Betamethasone Ointment. Pharmaceutical Research. 37(3). 52–52. 6 indexed citations
9.
Kos, Mojca Kerec, et al.. (2020). Does the Urothelium of Old Mice Regenerate after Chitosan Injury as Quickly as the Urothelium of Young Mice?. International Journal of Molecular Sciences. 21(10). 3502–3502. 6 indexed citations
10.
Kos, Mojca Kerec, et al.. (2019). Maturation of midazolam clearance in critically ill children with severe bronchiolitis: A population pharmacokinetic analysis. European Journal of Pharmaceutical Sciences. 141. 105095–105095. 3 indexed citations
11.
Erman, Andreja, et al.. (2017). Repeated treatments with chitosan in combination with antibiotics completely eradicate uropathogenic Escherichia coli from infected mouse urinary bladders. The Journal of Infectious Diseases. 216(3). jix023–jix023. 18 indexed citations
12.
Grabnar, Iztok, Mojca Kerec Kos, Tomaž Vovk, et al.. (2016). Bisoprolol pharmacokinetics and body composition in patients with chronic heart failure: a longitudinal study. European Journal of Clinical Pharmacology. 72(7). 813–822. 18 indexed citations
13.
Kos, Mojca Kerec, Stephan von Haehling, Stefan D. Anker, et al.. (2015). Iohexol clearance is superior to creatinine-based renal function estimating equations in detecting short-term renal function decline in chronic heart failure. Croatian Medical Journal. 56(6). 531–541. 6 indexed citations
14.
15.
Kos, Mojca Kerec, et al.. (2013). Pharmacokinetics of Drugs in Cachectic Patients: A Systematic Review. PLoS ONE. 8(11). e79603–e79603. 74 indexed citations
16.
Erman, Andreja, Mojca Kerec Kos, Simon Žakelj, et al.. (2013). Correlative study of functional and structural regeneration of urothelium after chitosan-induced injury. Histochemistry and Cell Biology. 140(5). 521–531. 25 indexed citations
17.
Kos, Mojca Kerec, et al.. (2009). PCN143 WILLINGNESS TO PAY FOR A LIFE-YEAR GAINED FROM THE PERSPECTIVE OF THE GENERAL POPULATION. Value in Health. 12(7). A284–A284. 1 indexed citations
18.
Kos, Mojca Kerec, Marija Bogataj, & Aleš Mrhar. (2008). Heparin Decreases Permeability of Pig Urinary Bladder Wall Preliminarily Enhanced by Chitosan. Drug Development and Industrial Pharmacy. 34(2). 215–220. 6 indexed citations
19.
Kos, Mojca Kerec, Marija Bogataj, Peter Veranič, & Aleš Mrhar. (2006). Permeability of Pig Urinary Bladder Wall: Time and Concentration Dependent Effect of Chitosan. Biological and Pharmaceutical Bulletin. 29(8). 1685–1691. 36 indexed citations
20.
Kos, Mojca Kerec, et al.. (2003). The influence of locally implanted high doses of gentamicin on hearing and renal function of newborns treated for acute hematogenous osteomyelitis. International Journal of Clinical Pharmacology and Therapeutics. 41(7). 281–286. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shih‐Yu Chen Breakdown of academic impact, for papers by Molouk Hadjibabaie Breakdown of academic impact, for papers by Hong Lu Breakdown of academic impact, for papers by Sadık Görür Breakdown of academic impact, for papers by Afshin Safaei Asl Breakdown of academic impact, for papers by Anders Rosén Breakdown of academic impact, for papers by Dennis H. Giesing Breakdown of academic impact, for papers by Vural Kesik Breakdown of academic impact, for papers by Kousalya Prabahar Breakdown of academic impact, for papers by Vincent P. Gotz
Rankless by CCL
2026